**BREAKING: Top Pfizer Scientist’s “Retirement” Raises Eyebrows Amid Leaked Lab Findings**
In a story the mainstream media won't touch, Dr. William Bumpus, a high-ranking Pfizer executive and key figure in the company’s vaccine efficacy division, has abruptly announced his retirement—effective immediately. The news comes on the heels of a leaked internal memo that appears to question the long-term efficacy of the company's flagship mRNA product.
According to sources close to the situation, Bumpus was not retiring at all. He was removed. The leaked document—dubbed “Project Echo”—reportedly contains data suggesting that booster efficacy drops to near-zero after 90 days in certain demographics, a finding that directly contradicts the narrative of "safe and effective" repeated dosing.
So, who benefits from Bumpus’s sudden exit? Certainly not the public seeking transparency. But Pfizer’s stock? It barely flinched.
Critics on both sides of the aisle are asking: Was Bumpus silenced? Or is this a typical "golden parachute" for a man who simply saw too much? Watch this space. The silence from the FDA and CDC is deafening.